Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0DR8N
|
|||
Former ID |
DNC004083
|
|||
Drug Name |
AZAKENPAULLONE
|
|||
Synonyms |
1-Azakenpaullone; 676596-65-9; azakenpaullone; 9-bromo-7,12-dihydropyrido[3',2':2,3]azepino[4,5-b]indol-6(5H)-one; C15H10BrN3O; Kinome_3492; 1-AKP; SCHEMBL378920; GTPL8018; CHEMBL336961; BDBM7497; DTXSID8042686; NOCAS_42686; CTK8F0375; MolPort-003-844-675; CHEBI:131490; HMS3653A17; HMS3229B07; BCP21061; ZINC13588927; s7193; 2138AH; 1-Azakenpaullone, > AKOS030240424; SB19270; TRA0006688; NCGC00386322-01; RT-006179; FT-0662368; SW220021-1; KS-00001866
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H10BrN3O
|
|||
Canonical SMILES |
C1C2=C(C3=C(C=CC=N3)NC1=O)NC4=C2C=C(C=C4)Br
|
|||
InChI |
1S/C15H10BrN3O/c16-8-3-4-11-9(6-8)10-7-13(20)18-12-2-1-5-17-15(12)14(10)19-11/h1-6,19H,7H2,(H,18,20)
|
|||
InChIKey |
NTSBZVCEIVPKBJ-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
11108285, 11644850, 15372145, 26758278, 43184116, 51054469, 56311921, 57370924, 58713088, 91610624, 99302632, 103368597, 103905441, 134341288, 141575106, 162248452, 163125287, 163688554, 164836020, 177218158, 180386960, 184024335, 184525734, 184525755, 184525776, 184533108, 204424124, 226710153, 241126228, 247082686, 249565698, 252261743, 252469926
|
|||
ChEBI ID |
CHEBI:131490
|
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8018). | |||
REF 2 | 1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3 beta. Bioorg Med Chem Lett. 2004 Jan 19;14(2):413-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.